Literature DB >> 22532679

Pathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitro.

Melissa W Hayes1, Ricardo Carrion, Jerritt Nunneley, Andrei E Medvedev, Maria S Salvato, Igor S Lukashevich.   

Abstract

Lymphocytic choriomeningitis virus (LCMV), the prototype arenavirus, and Lassa virus (LASV), the causative agent of Lassa fever (LF), have extensive strain diversity and significant variations in pathogenicity for humans and experimental animals. The WE strain of LCMV (LCMV-WE), but not the Armstrong (Arm) strain, induces a fatal LF-like disease in rhesus macaques. We also demonstrated that LASV infection of human macrophages and endothelial cells resulted in reduced levels of proinflammatory cytokines. Here we have shown that cells infected with LASV or with LCMV-WE suppressed Toll-like receptor 2 (TLR2)-dependent proinflammatory cytokine responses. The persisting isolate LCMV clone 13 (CL13) also failed to stimulate interleukin-6 (IL-6) in macrophages. In contrast, nonpathogenic Mopeia virus, which is a genetic relative of LASV and LCMV-Arm induced robust responses that were TLR2/Mal dependent, required virus replication, and were enhanced by CD14. Superinfection experiments demonstrated that the WE strain of LCMV inhibited the Arm-mediated IL-8 response during the early stage of infection. In cells transfected with the NF-κB-luciferase reporter, infection with LCMV-Arm resulted in the induction of NF-κB, but cells infected with LCMV-WE and CL13 did not. These results suggest that pathogenic arenaviruses suppress NF-κB-mediated proinflammatory cytokine responses in infected cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22532679      PMCID: PMC3416321          DOI: 10.1128/JVI.06508-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

Review 2.  Toll-like receptor signalling.

Authors:  Shizuo Akira; Kiyoshi Takeda
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

3.  Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses.

Authors:  Siddhartha Mahanty; Karen Hutchinson; Sudhanshu Agarwal; Michael McRae; Pierre E Rollin; Bali Pulendran
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

4.  Monocyte antigen CD14 is a phospholipid anchored membrane protein.

Authors:  D L Simmons; S Tan; D G Tenen; A Nicholson-Weller; B Seed
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

5.  Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus.

Authors:  Igor S Lukashevich; Mahmoud Djavani; Juan D Rodas; Juan C Zapata; Amy Usborne; Carol Emerson; Jacque Mitchen; Peter B Jahrling; Maria S Salvato
Journal:  J Med Virol       Date:  2002-06       Impact factor: 2.327

6.  Alterations in NF-kappaB and RBP-Jkappa by arenavirus infection of macrophages in vitro and in vivo.

Authors:  S M Fennewald; J F Aronson; L Zhang; N K Herzog
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

7.  Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells.

Authors:  Sylvain Baize; Jérôme Kaplon; Caroline Faure; Delphine Pannetier; Marie-Claude Georges-Courbot; Vincent Deubel
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

8.  Lassa fever. Effective therapy with ribavirin.

Authors:  J B McCormick; I J King; P A Webb; C L Scribner; R B Craven; K M Johnson; L H Elliott; R Belmont-Williams
Journal:  N Engl J Med       Date:  1986-01-02       Impact factor: 91.245

9.  Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus.

Authors:  Marcel Asper; Thomas Sternsdorf; Meike Hass; Christian Drosten; Antje Rhode; Herbert Schmitz; Stephan Günther
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

10.  Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation.

Authors:  Igor S Lukashevich; Ilia Tikhonov; Juan D Rodas; Juan C Zapata; Yida Yang; Mahmoud Djavani; Maria S Salvato
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more
  17 in total

1.  R753Q polymorphism inhibits Toll-like receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88.

Authors:  Yanbao Xiong; Chang Song; Greg A Snyder; Eric J Sundberg; Andrei E Medvedev
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

2.  Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response.

Authors:  Stéphanie Reynard; Marion Russier; Alexandra Fizet; Xavier Carnec; Sylvain Baize
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

3.  Highly Pathogenic New World and Old World Human Arenaviruses Induce Distinct Interferon Responses in Human Cells.

Authors:  Cheng Huang; Olga A Kolokoltsova; Nadezhda E Yun; Alexey V Seregin; Shannon Ronca; Takaaki Koma; Slobodan Paessler
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

Review 4.  The search for animal models for Lassa fever vaccine development.

Authors:  Igor S Lukashevich
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

Review 5.  Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer.

Authors:  Andrei E Medvedev
Journal:  J Interferon Cytokine Res       Date:  2013-05-15       Impact factor: 2.607

Review 6.  Host cell factors as antiviral targets in arenavirus infection.

Authors:  Florencia N Linero; Claudia S Sepúlveda; Federico Giovannoni; Viviana Castilla; Cybele C García; Luis A Scolaro; Elsa B Damonte
Journal:  Viruses       Date:  2012-09-13       Impact factor: 5.048

Review 7.  A systems biology starter kit for arenaviruses.

Authors:  Magali E Droniou-Bonzom; Paula M Cannon
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

Review 8.  Advanced vaccine candidates for Lassa fever.

Authors:  Igor S Lukashevich
Journal:  Viruses       Date:  2012-10-29       Impact factor: 5.048

9.  Transcriptional profiling of the circulating immune response to lassa virus in an aerosol model of exposure.

Authors:  Shikha Malhotra; Judy Y Yen; Anna N Honko; Sara Garamszegi; Ignacio S Caballero; Joshua C Johnson; Eric M Mucker; John C Trefry; Lisa E Hensley; John H Connor
Journal:  PLoS Negl Trop Dis       Date:  2013-04-25

Review 10.  Arenavirus evasion of host anti-viral responses.

Authors:  Melissa Hayes; Maria Salvato
Journal:  Viruses       Date:  2012-10-17       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.